Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00346528 · ClinicalTrials.gov registry record · Phase 3

Safety of NGOIS Compared to BSS Plus in Pediatric Patients

A Phase 3 study, sponsored by Alcon Research.

Completed
Registry status
Phase 3
Development phase
18
Enrollment target

NCT00346528: Completed Phase 3 study, sponsored by Alcon Research.

NCT00346528 is a Phase 3 study that has completed, run by Alcon Research. The registered enrollment target is 18 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00346528, a Phase 3 study, has completed, sponsored by Alcon Research.

COMPLETED
Registry status
Phase 3
Development phase
18 participants
Enrollment target

Study Summary

To evaluate the Safety of Next Generation Ophthalmic Irrigating Solution compared to BSS Plus for use during cataract surgery in Pediatric patients.

Interventions

  • DRUG BSS Plus
  • DRUG Next Generation Ophthalmic Irrigating Solution (NGOIS)

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2006-07
Est. Completion 2007-06
Phase Phase 3
Alcon Research

275 total trials

What the finished NCT00346528 record still lists

NCT00346528 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which BSS Plus is the first listed.

NCT00346528 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00346528 about?

NCT00346528 is a clinical study titled "Safety of NGOIS Compared to BSS Plus in Pediatric Patients". To evaluate the Safety of Next Generation Ophthalmic Irrigating Solution compared to BSS Plus for use during cataract surgery in Pediatric patients.

What is the current status of trial NCT00346528?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 18 participants. The study started on 2006-07. Estimated completion is 2007-06.

What interventions are being tested in trial NCT00346528?

The interventions under investigation include: BSS Plus (DRUG), Next Generation Ophthalmic Irrigating Solution (NGOIS) (DRUG).

Who is sponsoring clinical trial NCT00346528?

This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00346528's enrollment target sits among peer trials

18 1970th of 2000 higher than 30 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00346528, the US trial registry maintained by the National Library of Medicine. NCT00346528 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.